Literature DB >> 21113976

Complete COL1A1 allele deletions in osteogenesis imperfecta.

Fleur S van Dijk1, Margriet Huizer, Ariana Kariminejad, Carlo L Marcelis, Astrid S Plomp, Paulien A Terhal, Hanne Meijers-Heijboer, Marjan M Weiss, Rick R van Rijn, Jan M Cobben, Gerard Pals.   

Abstract

PURPOSE: To identify a molecular genetic cause in patients with a clinical diagnosis of osteogenesis imperfecta (OI) type I/IV.
METHODS: The authors performed multiplex ligation-dependent probe amplification analysis of the COL1A1 gene in a group of 106 index patients.
RESULTS: In four families with mild osteogenesis imperfecta and no other phenotypic abnormalities, a deletion of the complete COL1A1 gene on one allele was detected, a molecular finding that to our knowledge has not been described before, apart from a larger chromosomal deletion detected by fluorescent in situ hybridization encompassing the COL1A1 gene in a patient with mild osteogenesis imperfecta and other phenotypic abnormalities. Microarray analysis in three of the four families showed that it did not concern a founder mutation.
CONCLUSION: The clinical picture of complete COL1A1 allele deletions is a comparatively mild type of osteogenesis imperfecta. As such, multiplex ligation-dependent probe amplification analysis of the COL1A1 gene is a useful additional approach to defining the mutation in cases of suspected osteogenesis imperfecta type I with no detectable mutation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21113976     DOI: 10.1097/GIM.0b013e3181f01617

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  6 in total

1.  No evidence for disturbed COL1A1 and A2 expression in otosclerosis.

Authors:  Péter Csomor; Balázs Liktor; Bálint Liktor; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-01       Impact factor: 2.503

2.  Osteogenesis Imperfecta: A Review with Clinical Examples.

Authors:  F S van Dijk; J M Cobben; A Kariminejad; A Maugeri; P G J Nikkels; R R van Rijn; G Pals
Journal:  Mol Syndromol       Date:  2011-10-12

3.  EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta.

Authors:  Fleur S van Dijk; Peter H Byers; Raymond Dalgleish; Fransiska Malfait; Alessandra Maugeri; Marianne Rohrbach; Sofie Symoens; Erik A Sistermans; Gerard Pals
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

4.  COL1A2 polymorphic markers confer an increased risk of neovascular age-related macular degeneration in a Han Chinese population.

Authors:  Chengguo Zuo; Feng Wen; Meng Li; Xiongze Zhang; Hui Chen; Kunfang Wu; Renpan Zeng
Journal:  Mol Vis       Date:  2012-06-30       Impact factor: 2.367

5.  Tantalum implanted entangled porous titanium promotes surface osseointegration and bone ingrowth.

Authors:  Qi Wang; Yuqin Qiao; Mengqi Cheng; Guofeng Jiang; Guo He; Yunsu Chen; Xianlong Zhang; Xuanyong Liu
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

6.  A 235 Kb deletion at 17q21.33 encompassing the COL1A1, and two additional secondary copy number variants in an infant with type I osteogenesis imperfecta: A rare case report.

Authors:  Numbereye Numbere; David R Weber; George Porter; Mohammed A Iqbal
Journal:  Mol Genet Genomic Med       Date:  2020-04-13       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.